Protecting the world against pertussis and other global re-emerging diseases
BioNet is a vaccine manufacturer specializing in the development of recombinant and mRNA vaccines against respiratory diseases and other global public health threats. BioNet has a strong track record with development and biomanufacturing, having advanced many proprietary recombinant pertussis vaccines from early R&D to licensure. It currently markets multiple vaccines through its established commercial network. BioNet has been rapidly expanding its operations across all continents.
State-of-the-art manufacturing capabilities
BioNet commits to develop and manufacture innovative high-quality vaccines that comply with applicable regulatory requirements. BioNet aims to integrate quality beyond compliance in both products and processes through continuous improvement of our quality system.
Our vaccines are manufactured in accordance to Good Manufacturing Practices (GMP) PIC/S standards, and tested at each manufacturing step as per pharmacopeia requirements in our own quality control and testing facilities.
BioNet Key Facts
3
licensed
recombinant pertussis vaccines
200+
collaborators
sharing their passion for vaccines
30+
years’ experience
in international management
20+
clinical trials experience
10+
mRNA
candidates
Our latest news!
BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA)
“Monovalent recombinant acellular pertussis vaccine proven to significantly boost immunity against pertussis”
Lyon, France – July 31, 2024, BioNet Europe, the French subsidiary of BioNet, a vaccine manufacturer specializing in the development of genetically engineered vaccines, has announced the submission of a centralized Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its monovalent Recombinant Pertussis Vaccine (RPV).
BioNet’s stand-alone vaccine targets whooping cough, a highly contagious respiratory disease on the steep rise across Europe. This non-combined vaccine is tailored to the persons who require pertussis-only booster vaccination and are up-to-date with their diphtheria and tetanus immunizations.
